Latest News & Features
Europe
Supplementary Protection Certificate rules interpreted in different ways have left the EU’s generic and biosimilar industries hungry for clarity, explains Jiri Slavik of Adalvo. 25 March 2025
Europe
New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products. 20 March 2025
Americas
Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA. 20 March 2025
Americas
Companies are transforming IP from a defensive tool into a revenue-generating powerhouse. Marisa Woutersen at the WIPR Summit 2025 hears trends in licensing, platform-based monetisation, and litigation funding. 18 March 2025
Americas
Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies. 18 March 2025
Americas
As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen. 13 March 2025
Americas
If law firms begin to fear the political repercussions of doing their jobs, the ‘whole system could unravel’. Muireann Bolger finds a concerned profession looking for leaders to oppose ‘open retribution’. 13 March 2025
Americas
John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation signals a positive shift for the office. 13 March 2025
Big Pharma
The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun Pharma. 11 March 2025
Americas
Appeals court affirms PTAB’s invalidation of three heart monitoring patents | Decision voids limited exclusion order that temporarily halted Apple watch imports into the US. 11 March 2025